Prolight Diagnostics

Prolight Diagnostics AB is a Swedish company based in Stockholm, established in 1999. The company specializes in developing innovative Point-of-Care (POC) diagnostic systems that provide rapid and reliable in-vitro diagnostic testing outside traditional hospital settings. Their portable instruments and disposable cartridges allow healthcare professionals to conduct tests using just a drop of blood, facilitating quick and accurate decision-making in various environments, including emergency departments and healthcare centers. The company's core technology is built on a patented micro ELISA platform, enhanced by the acquisition of Psyros Diagnostics Ltd in 2022, which introduced advanced digital immunoassay technology. This enables highly sensitive protein measurements, such as troponin, crucial for diagnosing acute cardiac events. Prolight Diagnostics aims to deliver test results within ten minutes, supporting timely treatment and improved patient flow. Their offerings include POC testing systems, micro flex and flex membrane technologies, and digital high-sensitive immunoassays for detecting low-concentration biomarkers. The company serves healthcare providers, including emergency rooms, medical centers, and nursing homes, enhancing patient outcomes and healthcare efficiency.

• Employees 20